Literature DB >> 2397181

Coagulation abnormalities in chronic peritoneal dialysis.

C L Jones1, M Andrew, A Eddy, M O'Neil, N I Shalom, J W Balfe.   

Abstract

To determine whether children treated with chronic peritoneal dialysis have a hypercoagulable state, various coagulation and fibrinolytic factor concentrations or activities were measured in 17 children undergoing chronic peritoneal dialysis. The patients had significantly increased activities of factors VII and VIII, and increased concentrations of von Willebrand factor (vWF), fibrinogen, factor XIIIA and factor XIIIS compared to reference values (P less than 0.001 in each case). The activated partial thromboplastin time was prolonged (P less than 0.001) and the thrombin clotting time was decreased (P less than 0.05) in these children. The prothrombin time and activities of factors XII, XI, IX, X, V and II were not significantly different from control values. Protein C concentrations were similar to normal, but antithrombin III concentrations were increased (P less than 0.05). Within the fibrinolytic pathway, decreased concentrations of plasminogen were found (P less than 0.001) and the concentrations of alpha-2-antiplasmin were increased (P less than 0.001). The plasma albumin concentration was below 33 g/l in 13 of the 17 children. The duration of treatment with peritoneal dialysis was directly correlated with vWF concentrations (P less than 0.001) and inversely correlated with factor VII concentrations (P less than 0.01). Of these patients 2 have since had clinical thrombotic episodes. The coagulation abnormalities found may have a role in the occurrence of thrombosis complicating renal transplantation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2397181     DOI: 10.1007/bf00858827

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

Review 1.  Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.

Authors:  F Llach
Journal:  Kidney Int       Date:  1985-09       Impact factor: 10.612

2.  Nephrotic syndrome and coagulation and fibrinolytic abnormalities.

Authors:  N D Vaziri
Journal:  Am J Nephrol       Date:  1983 Jan-Feb       Impact factor: 3.754

3.  Protein losses during peritoneal dialysis.

Authors:  M J Blumenkrantz; G M Gahl; J D Kopple; A V Kamdar; M R Jones; M Kessel; J W Coburn
Journal:  Kidney Int       Date:  1981-04       Impact factor: 10.612

4.  Development of the human coagulation system in the full-term infant.

Authors:  M Andrew; B Paes; R Milner; M Johnston; L Mitchell; D M Tollefsen; P Powers
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

5.  Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults.

Authors:  O Mehls; K Andrassy; J Koderisch; U Herzog; E Ritz
Journal:  J Pediatr       Date:  1987-06       Impact factor: 4.406

6.  Plasma factor XIII levels in children with renal disease.

Authors:  K Yoshioka; H Miyata; Y Uraoka; S Maki
Journal:  Nephron       Date:  1981       Impact factor: 2.847

7.  Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome.

Authors:  V De Stefano; L Triolo; D De Martini; R Ferrelli; R Mori; G Leone
Journal:  J Lab Clin Med       Date:  1987-05

8.  Course and resolution of the coagulopathy in nephrotic children.

Authors:  N Alkjaersig; A P Fletcher; M Narayanan; A M Robson
Journal:  Kidney Int       Date:  1987-03       Impact factor: 10.612

9.  Thromboembolic complications in children with nephrotic syndrome. Risk and incidence.

Authors:  P F Hoyer; S Gonda; M Barthels; H P Krohn; J Brodehl
Journal:  Acta Paediatr Scand       Date:  1986-09

10.  Ménétrièr's disease and idiopathic hypertrophic gastropathy.

Authors:  R M Searcy; J R Malagelada
Journal:  Ann Intern Med       Date:  1984-04       Impact factor: 25.391

View more
  3 in total

1.  Protein Z and natural anticoagulants in children on peritoneal dialysis and hemodialysis.

Authors:  Kenan Bek; Ozan Ozkaya; Tunç Fişgin; Yüksel Aliyazicioğlu; M Sükrü Paksu; Tolga Ozgen; Davut Albayrak; Kemal Baysal
Journal:  Pediatr Nephrol       Date:  2006-11-24       Impact factor: 3.714

2.  Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis.

Authors:  J Alwakeel; A M Gader; S Hurieb; A K al-Momen; A Mitwalli; H Abu Aisha
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  Secretory activity of the coronary artery endothelial cells in conditions of the peritoneal dialysis.

Authors:  Monika Misian; Ewa Baum; Andrzej Bręborowicz
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.